Efficient Inhibition of Human Telomerase Activity by Antisense Oligonucleotides Sensitizes Cancer Cells to Radiotherapy
Overview
Authors
Affiliations
Aim: To investigate the effect of the antisense oligonucleotides (ASODN) specific for human telomerase RNA (hTR) on radio sensitization and proliferation inhibition in human neurogliocytoma cells (U251).
Methods: U251 cells were transfected with hTR ASODN or nonspecific oligonucleotides (NSODN). Before and after irradiation of (60)Co- gamma ray, telomerase activity was assayed by telomeric repeat amplification protocol ( TRAP-PCR-ELISA), and DNA damage and repair were examined by the comet assay. The classical colony assay was used to plot the cell-survival curve, to detect the D(0 )value.
Results: hTR antisense oligonucleotides could downregulate the telomerase activity, increase radiation induced DNA damage and reduce the subsequent repair. Furthermore, it could inhibit the proliferation and decrease the D(0 ) value which demonstrates rising radiosensitivity. However, telomere length was unchanged over a short period of time.
Conclusion: These findings suggest that an ASODN-based strategy may be used to develop telomerase inhibitors, which can efficiently sensitize radiotherapy.
Senescence of Tumor Cells in Anticancer Therapy-Beneficial and Detrimental Effects.
Piskorz W, Cechowska-Pasko M Int J Mol Sci. 2022; 23(19).
PMID: 36232388 PMC: 9570404. DOI: 10.3390/ijms231911082.
Bavelaar B, Song L, Jackson M, Able S, Tietz O, Skaripa-Koukelli I Mol Pharm. 2021; 18(10):3820-3831.
PMID: 34449222 PMC: 8493550. DOI: 10.1021/acs.molpharmaceut.1c00442.
Possibility of inducing tumor cell senescence during therapy.
Wang G, Cheng X, Zhang J, Liao Y, Jia Y, Qing C Oncol Lett. 2021; 22(1):496.
PMID: 33981358 PMC: 8108274. DOI: 10.3892/ol.2021.12757.
Chen K, Li L, Qu S, Pan X, Sun Y, Wan F Aging (Albany NY). 2020; 12(24):25599-25613.
PMID: 33234740 PMC: 7803545. DOI: 10.18632/aging.104167.
Jackson M, Bavelaar B, Waghorn P, Gill M, El-Sagheer A, Brown T Cancer Res. 2019; 79(18):4627-4637.
PMID: 31311806 PMC: 7611324. DOI: 10.1158/0008-5472.CAN-18-3594.